# US 2018/0024135 A1 · Multifunctional magneto-polymeric nanosystems for rapid targeting, isolation, detection and simultaneous imaging of circulating tumor cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0024135 A1
- Document ID: US20180024135A1
- Status: Published application
- Kind: A1
- Application number: 15/551,865
- Filed: 2016-02-15
- Published: 2018-01-25
- Earliest claimed: 2015-02-19
- Applicants: Actorius Innovations and Research Pvt. Ltd.
- Inventors: Jayant Jagannath Khandare; Shashwat Banerjee; Muralidhara Padigaru; Ganesh Khutale
- Web page: https://patentgrep.com/patent/US20180024135A1

## CPC

- G01N 33/5759: {involving compounds localised on the membrane of tumour or cancer cells}
- C07K 16/30: from tumour cells
- G01N 21/359: using near infrared light
- G01N 33/54326: {Magnetic particles}
- G01N 33/54346: {Nanoparticles}
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- G01N 33/553: Metal or metal coated
- G01N 33/6893: {related to diseases not provided for elsewhere}
- G01N 2333/4712: Muscle proteins, e.g. myosin, actin, protein
- G01N 2333/705: Assays involving receptors, cell surface antigens or cell surface determinants
- G01N 2800/324: Coronary artery diseases, e.g. angina pectoris, myocardial infarction
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A biofunctional multicomponent nanosystem for specific targeting, rapid isolation and simultaneous high resolution imaging of cancer cells is disclosed.

## Claims

### Claim 1

1) A biofunctional multicomponent nanosystem comprising:
(i) cells or antibodies selected from the group consisting of transferrin (Tf)/anti EpCam, CTC specific antibody targeting cancer cells and antibodies associated with cell or proteins for biomolecule interactions;
(ii) iron oxide (Fe3O4) nanoparticles;
(iii) cyanine 5 NHS (Cy5) near infrared probe;
(v) carbon allotropes for interaction with cancer cells;
(vi) poly(N-isopropylacrylamide) (PNIPAM);
(vii) fourth generation (G4) dendrimers or polymers selected from the group consisting of polyglycerols, polyamines and hyperbranched polymers; and
(viii) glutathione (GSH) for specific targeting, isolation and imaging of circulating cancer cells

### Claim 2 (depends on 1)

2) The biofunctional multicomponent nanosystem of claim 1, wherein the said carbon allotrope is selected from the group consisting of single or multiwalled carbon nanotubes, graphene and nanohorns.

### Claim 3 (depends on 1)

3) The biofunctional multicomponent nanosystem of claim 1, wherein the said fourth generation (G4) dendrimers or polymers are coupled to COOH, NH2, OH or other reactive groups.

### Claim 4

4) A process of synthesizing a biofunctional multicomponent nanosystem comprising the steps of:
a) synthesizing Fe3O4 magnetic nanoparticles by co-precipitating Fe2+ and Fe3+ ions by ammonia solution and treating under hydrothermal conditions;
b) anchoring of glutathione with Fe3O4;
c) synthesis of Fe3O4-GSH-PAMAM G4 dendrimer conjugate;
d) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene conjugate;
e) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene-Cy5-Tf conjugate; and
f) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene-Cy5-anti EpCam conjugate.

### Claim 5

5) A process of synthesizing a biofunctional multicomponent nanosystem comprising the steps of:
a) synthesizing Fe3O4 magnetic nanoparticles by co-precipitating Fe2+ and Fe3+ ions by ammonia solution and treating under hydrothermal conditions;
b) anchoring of glutathione with Fe3O4;
c) synthesis of Fe3O4-GSH-PAMAM G4 dendrimer conjugate;
d) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene conjugate;
e) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene PNIPAM conjugate
f) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene PNIPAM-Tf conjugate; and
g) synthesis of Fe3O4-GSH-PAMAM G4-CNT or graphene PNIPAM-anti EpCam conjugate.

### Claim 6

6) A biofunctional multicomponent nanosystem comprising:
(i) transferrin (Tf)/anti EpCam or any other CTC specific antibody or biomolecules interacting antibodies specifically targeting cancer cells;
(ii) iron oxide (Fe3O4) nanoparticles to allow magnetic isolation;
(iii) cyanine 5 NHS (Cy5) near infra red probe to enable simultaneous high-resolution imaging of the isolated CTCs;
(v) carbon allotrope for interaction with cancer cells;
(vi) poly(N-isopropylacrylamide) (PNIPAM), capable of affecting conformational structural changes and solubility enhancer, resulting in cancer cell capture;
(vii) fourth generation (G4) dendrimers or polymers selected from the group consisting of polyglycerols, polyamines and hyperbranched polymers; and
(viii) glutathione (GSH) for specific targeting, isolation and imaging of circulating cancer cells.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

A biofunctional multicomponent nanosystem of claims 1 to 6 used for cancer diagnosis.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

A biofunctional multicomponent nanosystem of claims 1 to 6 comprising diagnosis of acute myocardial infarction by detecting Troponin T levels in blood using specific anti-troponin-magnetic systems.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

A biofunctional multicomponent nanosystem of claims 1 to 6 comprising diagnosis of infectious diseases by immunomagnetic separation of pathogenic organisms from environmental matrices.

### Claim 10

A kit comprising a biofunctional multicomponent nanosystem comprising cells or antibodies selected from the group consisting of transferrin (Tf)/anti EpCam, CTC specific antibody targeting cancer cells and antibodies associated with cell or proteins, iron oxide (Fe3O4) nanoparticles, cyanine 5 NHS (Cy5) near infra red probe, carbon allotropes, poly(N-isopropylacrylamide) (PNIPAM), fourth generation (G4) dendrimers or polymers like polyglycerols/polyimines and glutathione (GSH).
